Spun out of the University of Oxford in 2005, this company specialises in compact DNA/RNA sequencing technology for biological research. The business has developed devices that help scientists identify bacteria and viruses, track disease outbreaks and study the DNA of humans, animals and plants. Led by co-founder and chief executive Gordon Sanghera, 58, it sells to nearly 100 countries. Revenues hit £32.5m last year. It has secured £451m in funding from investors including Woodford, and was valued at £1.5bn last March.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.